(SNDX) Syndax Pharmaceuticals - Performance -50.8% in 12m
Compare SNDX with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-41.82%
#51 in Group
Rel. Strength
16.55%
#6640 in Universe
Total Return 12m
-50.80%
#85 in Group
Total Return 5y
-40.39%
#49 in Group
P/E -
(?) Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -27.13%
(?) Percentile in Group
12m Total Return: SNDX (-50.8%) vs XBI (-12.3%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
UTHR NASDAQ United Therapeutics |
10.1% | 18% | 166% | 12.1 | 11 | 1.43 | 74.6% | 16.1% |
HLN NYSE Haleon |
14.3% | 31.2% | 47% | 24.4 | 20.2 | 1.79 | 69.1% | 13.6% |
AMGN NASDAQ Amgen |
-2.93% | -8.78% | 30.7% | 25.5 | 13.5 | 0.95 | 0.60% | 41% |
LONN SW Lonza |
9.55% | 9.34% | 30.4% | 67.1 | 35.1 | 1.28 | 2.20% | -12.5% |
BIM PA Biomerieux |
0.78% | 17.8% | -2.14% | 32.5 | 25.2 | 1.52 | -38.5% | -25.1% |
KMDA NASDAQ Kamada |
21.4% | 25.3% | -4.13% | 26.6 | 23.9 | 0.96 | 32.5% | 3.93% |
NBIX NASDAQ Neurocrine Biosciences |
34.3% | -15.5% | 3.48% | 32.3 | 21.6 | 0.27 | 68.0% | 31.9% |
ERF PA Eurofins Scientific SE |
20.4% | -0.39% | 7.63% | 26.6 | 13.6 | 0.56 | -66.6% | -17.1% |
Performance Comparison: SNDX vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for SNDX
Total Return (including Dividends) | SNDX | XBI | S&P 500 |
---|---|---|---|
1 Month | 4.26% | 11.81% | 13.81% |
3 Months | -27.23% | -13.61% | -6.30% |
12 Months | -50.80% | -12.29% | 10.65% |
5 Years | -40.39% | -24.89% | 107.77% |
Trend Score (consistency of price movement) | SNDX | XBI | S&P 500 |
1 Month | 26.4% | 72.9% | 83% |
3 Months | -68.6% | -83% | -75.3% |
12 Months | -87.9% | -51.6% | 50.1% |
5 Years | -1.70% | -53.9% | 84.1% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #98 | -6.75% | -8.39% |
3 Month | #67 | -15.8% | -22.3% |
12 Month | #85 | -43.9% | -55.5% |
5 Years | #50 | -20.6% | -71.3% |
FAQs
Does SNDX Syndax Pharmaceuticals outperforms the market?
No,
over the last 12 months SNDX made -50.80%, while its related Sector, the SPDR S&P Biotech (XBI) made -12.29%.
Over the last 3 months SNDX made -27.23%, while XBI made -13.61%.
Over the last 3 months SNDX made -27.23%, while XBI made -13.61%.
Performance Comparison SNDX vs Indeces and Sectors
SNDX vs. Indices SNDX is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | -21.5% | -9.55% | -44.6% | -61.5% |
US NASDAQ 100 | QQQ | -21.7% | -13.1% | -44.8% | -62.4% |
US Dow Jones Industrial 30 | DIA | -21.9% | -5.73% | -44.3% | -58.5% |
German DAX 40 | DAX | -21.5% | -10.7% | -70.9% | -76.5% |
Shanghai Shenzhen CSI 300 | CSI 300 | -23.7% | -7.57% | -45.4% | -58.2% |
Hongkong Hang Seng | HSI | -24.7% | -15.7% | -52.9% | -64.5% |
India NIFTY 50 | INDA | -16.6% | -0.58% | -45.0% | -50.6% |
Brasil Bovespa | EWZ | -22.6% | -13.0% | -53.3% | -42.5% |
SNDX vs. Sectors SNDX is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | -22.2% | -9.15% | -51.6% | -72.4% |
Consumer Discretionary | XLY | -21.9% | -9.97% | -43.6% | -65.1% |
Consumer Staples | XLP | -20.7% | -2.33% | -51.5% | -59.9% |
Energy | XLE | -21.3% | -2.50% | -38.0% | -41.3% |
Financial | XLF | -22.6% | -9.26% | -51.7% | -73.2% |
Health Care | XLV | -18.5% | 3.39% | -39.6% | -46.7% |
Industrial | XLI | -23.2% | -12.6% | -46.0% | -61.8% |
Materials | XLB | -21.3% | -9.30% | -39.7% | -45.6% |
Real Estate | XLRE | -20.2% | -7.28% | -45.3% | -66.3% |
Technology | XLK | -22.6% | -17.0% | -41.7% | -57.9% |
Utilities | XLU | -21.6% | -5.33% | -52.2% | -68.3% |
Aerospace & Defense | XAR | -23.5% | -16.9% | -56.1% | -78.1% |
Biotech | XBI | -14.9% | -7.55% | -24.4% | -38.5% |
Homebuilder | XHB | -22.0% | -7.22% | -31.4% | -43.3% |
Retail | XRT | -23.4% | -10.4% | -40.3% | -49.3% |